DongKook Pharmaceutical Co (XKRX:086450) COGS-to-Revenue : 0.45 (As of Sep. 2024)

View and export this data going back to 2007. Start your Free Trial

What is DongKook Pharmaceutical Co COGS-to-Revenue?

DongKook Pharmaceutical Co's Cost of Goods Sold for the three months ended in Sep. 2024 was ₩89,439 Mil. Its Revenue for the three months ended in Sep. 2024 was ₩200,879 Mil.

DongKook Pharmaceutical Co's COGS to Revenue for the three months ended in Sep. 2024 was 0.45.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. DongKook Pharmaceutical Co's Gross Margin % for the three months ended in Sep. 2024 was 55.48%.

DongKook Pharmaceutical Co COGS-to-Revenue Historical Data

The historical data trend for DongKook Pharmaceutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DongKook Pharmaceutical Co COGS-to-Revenue Chart

DongKook Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.40

0.41

0.43

0.44

DongKook Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
COGS-to-Revenue	Get a 7-Day Free Trial															0.43	0.44	0.44	0.45	0.45

DongKook Pharmaceutical Co COGS-to-Revenue Calculation

DongKook Pharmaceutical Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	320212.652	/	730993.597
	=	0.44

DongKook Pharmaceutical Co's COGS to Revenue for the quarter that ended in Sep. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	89439.038	/	200878.562
	=	0.45

DongKook Pharmaceutical Co (XKRX:086450) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

DongKook Pharmaceutical Co's Gross Margin % for the three months ended in Sep. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	89439.038 / 200878.562
	=	55.48 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

DongKook Pharmaceutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of DongKook Pharmaceutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

DongKook Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DongKook Pharmaceutical Co Ltd (XKRX:086450) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

Dongkook Building 997-8 Daechi 3-dong, Kangnam-gu, Seoul, KOR, 135-502

Website

http://www.dkpharm.co.kr

DongKook Pharmaceutical Co Ltd is a part of the healthcare industry based in Korea. Being a pharmaceutical company, its activities are focused on the research and development of drugs. The company produces superior medicines used favorably by consumers such as Madecassol, which is a drug for wounds and Oramedy, which is a drug for treating stomatitis. It also owns a prefilled syringe system in its second factory, through which it produces various kinds of ultramodern injection agents.

DongKook Pharmaceutical Co Headlines

No Headlines